Category News

Noramco Invests $25M in Halo Pharma’s Whippany Facility for Sterile Injectables

Noramco Invests $25M in Halo Pharma’s Whippany Facility for Sterile Injectables

Noramco Group Announces $25 Million Investment in Halo Pharma’s Whippany Facility for Sterile Injectable Manufacturing The Noramco Group, a prominent North American provider of integrated Active Pharmaceutical Ingredient (API) and drug product supply chain services, has made a strategic $25…

Read MoreNoramco Invests $25M in Halo Pharma’s Whippany Facility for Sterile Injectables
Ionis Pharmaceuticals, Inc. has announced that its partnership with AstraZeneca has led to the approval of WAINZUA (eplontersen) by the European Union (EU)

WAINZUA (eplontersen) EU-Approved for Stage 1/2 Hereditary Transthyretin-Mediated Amyloido

Ionis Pharmaceuticals, Inc. has announced that its partnership with AstraZeneca has led to the approval of WAINZUA (eplontersen) by the European Union (EU) for the treatment of hereditary transthyretin-mediated amyloidosis (hATTR) in adults with stage 1 or stage 2 polyneuropathy.…

Read MoreWAINZUA (eplontersen) EU-Approved for Stage 1/2 Hereditary Transthyretin-Mediated Amyloido
BASF, Somaiya Vidyavihar, and Indian Chemical Council Showcase

BASF, Somaiya Vidyavihar, and Indian Chemical Council Showcase Progress of We-Chemie Program 2024

BASF, Somaiya Vidyavihar, and Indian Chemical Council Celebrate Progress of We-Chemie Program BASF India, in collaboration with Somaiya Vidyavihar (SVV) and the Indian Chemical Council (ICC), proudly marks a significant milestone in the We-Chemie program, celebrating its accomplishments since its…

Read MoreBASF, Somaiya Vidyavihar, and Indian Chemical Council Showcase Progress of We-Chemie Program 2024
AskBio Advances Gene Therapy Trial for Limb-Girdle Muscular Dystrophy with Dosing of Second Cohort

AskBio Advances Gene Therapy Trial for Limb-Girdle Muscular Dystrophy with Dosing of Second Cohort

AskBio Advances Gene Therapy Trial for Limb-Girdle Muscular Dystrophy Type 2I/R9 AskBio Inc., a leading gene therapy company wholly owned by Bayer AG, has announced a significant milestone in its Phase 1/Phase 2 LION-CS101 clinical trial for the investigational gene…

Read MoreAskBio Advances Gene Therapy Trial for Limb-Girdle Muscular Dystrophy with Dosing of Second Cohort
Aerospace & Life Sciences Testing and Certification Industry Report 2025

Aerospace & Life Sciences Testing and Certification Industry Report 2025

Aerospace & Life Sciences Testing, Inspection, and Certification Market Overview has been added to ResearchAndMarkets.com’s offering. The global market for Aerospace & Life Sciences Testing, Inspection, and Certification (TIC) services is expected to grow significantly in the coming years. Valued at approximately…

Read MoreAerospace & Life Sciences Testing and Certification Industry Report 2025